Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This study included participants from 8 diabetes centers across 5 regions of Saudi Arabia, making it the largest multicenter prospective study to evaluate not only glycemic outcomes, but also the fasting experience and patient-reported outcomes (PROMs) during Ramadan
Our mission is to empower you with the tools to take control of your health journey
This table helps patients understand which symptoms may be mild and which symptoms should be reviewed by a provider
A 2025 study published in The Lancet Diabetes & Endocrinology found that a 7.2-milligram dose of semaglutide led to an average of 3% greater weight loss over 72 weeks compared with the 2.4-milligram dose
Ready to Transform
US$ 24.88
US$ 24.17
US$ 25.80
